Skip to content

Serum/plasma *Substance concentration* by immunoassay (tetramethylbenzidine signal) for *Escherichia coli* antigen detection

Published: August 9, 2026Updated: August 16, 2026

This test measures the presence of *Escherichia coli* bacteria in your blood or plasma using an immunoassay method. It helps identify infections caused by this common gut bacterium that may have spread beyond the intestines.

Quick summary

["Detects bloodstream infections by *E. coli* with a simple blood draw."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
105770-2
Short code
P aerugns DNA Ct Bld Pos Qn NAA+probe
Synonyms
P aerugns DNA Ct Bld Pos Qn NAA+probe
Category
chemistry
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
probe-amp-tar
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

What This Test Measures

The test detects *Escherichia coli* antigens in your blood or plasma. Antigens are specific molecular markers that the immune system recognizes as foreign. This test specifically looks for proteins produced by *E. coli* bacteria, which can indicate an active infection.

Why It’s Done

Your healthcare provider may order this test if you have symptoms like fever, chills, or signs of infection such as rapid heartbeat or confusion, especially if you’ve recently had a urinary tract infection, surgery, or a condition that weakens your immune system.

When Results Might Be Abnormal

If the test is positive, it suggests the presence of *E. coli* in your blood, which could indicate a serious infection requiring immediate medical attention. Negative results mean no detectable *E. coli* antigens were found in this sample.

What to Expect Before the Test

No special preparation is needed. You’ll have a small needle inserted into a vein (usually in your arm) to draw a blood sample. The process is quick and usually painless.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test is primarily used to diagnose bloodstream infections caused by *E. coli*. It can help confirm if the bacteria have spread beyond the gastrointestinal tract, guiding treatment decisions such as starting antibiotics.

Short name

E. coli Antigen (Serum/Plasma) IA-TMB

Frequently asked questions

What does a positive result mean?
A positive result means your blood or plasma contains detectable *E. coli* antigens, indicating an active infection. Your healthcare provider will discuss next steps, which may include starting antibiotics or further testing.
Can this test detect all types of *E. coli* infections?
This test detects *E. coli* antigens broadly but may not distinguish between different strains or specific types of infections. It’s most useful for confirming bloodstream infections caused by this bacterium.
How soon will I get my results?
Results are typically available within 24 to 48 hours, depending on your lab’s processing schedule. Your healthcare provider will contact you with the results and any needed follow-up.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy